Published in:
01-10-2009 | Invited Paper
Classification and controversies in pathology of ependymomas
Author:
Catherine Godfraind
Published in:
Child's Nervous System
|
Issue 10/2009
Login to get access
Abstract
Purpose
Bailey and Cushing established ependymoma as a brain tumour entity in the first brain tumour classification (1926). Diagnosis of ependymomas is not subject to controversy as long as other tumours presenting ependymoma-like features have been ruled out. Grading conversely is a source of debate. Description of histological features establishing diagnosis and grading of ependymomas may help to better understand this controversy.
Methods
Literature has been reviewed using PubMed with the following key words: ependymoma, +/− prognosis, +/− biomaker, +/− grading, +/− immunohistochemistry, +/− proliferative index.
Results
Grading controversy arises from elusive WHO features and individual characteristics of ependymomas including tumour location, tumour pattern/variant and variable expression of biomarkers.
Conclusion
There is a need for a grading scheme with a proven general ability to dissociate grades, and to predict individual clinical evolution. Only then will stratified and targeted therapeutics for ependymal tumours be possible.